This University Startup Found Strong Support and Space Without Leaving Town

Published on :

Biomedical innovations can take a decade or more of ongoing research and development before they are ready to be used to treat patients. Even with funding and expert scientists, the most promising technologies can fail to go to market if entrepreneurs don’t have the experience or support to navigate the long and tedious drug development process.
A local resource is helping university-founded startups find success.
From a small lab space within the University of Maryland School of Medicine, Distinguished University Professor Vincent C.O. Njar, Ph.D., made an incredible discovery. Through his research, he developed novel small molecules with the potential to inhibit the growth of and treat breast cancer, with possible applications in dermatology and other types of cancer. Dr. Njar’s discovery could offer better outcomes for a range of patients.
To help clear the path to market, University of Maryland, Baltimore’s (UMB) New Ventures team worked with Dr. Njar to establish his startup, Isoprene Pharmaceuticals, Inc. The New Ventures program, run by a team with

5 Questions with Leah Sera, PharmD, MA, BCPS, Program Director, MS in Medical Cannabis Science and Therapeutics (MCST), Associate Professor, University of Maryland School of Pharmacy

Published on :

Leah Sera, PharmD, MA, BCPS, is the Program Director, MS in Medical Cannabis Science and Therapeutics (MCST), and an Associate Professor, University of Maryland School of Pharmacy. She is currently an associate professor in the Department of Pharmacy Practice and Science. Her clinical specialties are pain management and palliative care.

The ‘Big House’ for Genomics Stands Proudly Here in Baltimore at UMB

Published on :

The ‘Big House’ for Genomics Stands Proudly Here in Baltimore at UMB November 21, 2017 Hundreds gathered last week at the University of Maryland, Institute for Genome Sciences(@GenomeScience) for the annual “Frontiers [….]